News Industry News Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure July 23, 2019
News Industry News Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study July 22, 2019
News Industry News New study finds both components of blood pressure predict heart attack, stroke risk July 17, 2019
News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Industry News Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries April 16, 2019